387 related articles for article (PubMed ID: 11896065)
1. Hodgkin's lymphoma: the pathologist's viewpoint.
Pileri SA; Ascani S; Leoncini L; Sabattini E; Zinzani PL; Piccaluga PP; Pileri A; Giunti M; Falini B; Bolis GB; Stein H
J Clin Pathol; 2002 Mar; 55(3):162-76. PubMed ID: 11896065
[TBL] [Abstract][Full Text] [Related]
2. Pathobiology of hodgkin lymphoma.
Piccaluga PP; Agostinelli C; Gazzola A; Tripodo C; Bacci F; Sabattini E; Sista MT; Mannu C; Sapienza MR; Rossi M; Laginestra MA; Sagramoso-Sacchetti CA; Righi S; Pileri SA
Adv Hematol; 2011; 2011():920898. PubMed ID: 21253495
[TBL] [Abstract][Full Text] [Related]
3. Pathobiology of hodgkin lymphoma.
Agostinelli C; Pileri S
Mediterr J Hematol Infect Dis; 2014; 6(1):e2014040. PubMed ID: 24959337
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin's disease: classification and differential diagnosis.
Harris NL
Mod Pathol; 1999 Feb; 12(2):159-75. PubMed ID: 10071341
[TBL] [Abstract][Full Text] [Related]
5. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
6. The many faces of Hodgkin's disease around the world: what have we learned from its pathology?
Harris NL
Ann Oncol; 1998; 9 Suppl 5():S45-56. PubMed ID: 9926237
[TBL] [Abstract][Full Text] [Related]
7. [Hodgkin lymphoma. Classification and pathogenesis].
Foss HD; Marafioti T; Stein H
Pathologe; 2000 Mar; 21(2):113-23. PubMed ID: 10840817
[TBL] [Abstract][Full Text] [Related]
8. Pathology and "molecular histology' of Hodgkin's disease and the border to non-Hodgkin's lymphomas.
Hansmann ML; Küppers R
Baillieres Clin Haematol; 1996 Sep; 9(3):459-77. PubMed ID: 8922240
[TBL] [Abstract][Full Text] [Related]
9. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
Peh SC; Kim LH; Poppema S
Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
[TBL] [Abstract][Full Text] [Related]
10. Is Hodgkin's disease a unique entity?
Pileri SA; Poggi S; Sabattini E; De Vivo A; Falini B; Stein H
Leuk Lymphoma; 1995; 15 Suppl 1():3-6. PubMed ID: 7767257
[TBL] [Abstract][Full Text] [Related]
11. The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.
Cool CD; Bitter MA
Hum Pathol; 1997 Sep; 28(9):1026-33. PubMed ID: 9308726
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of lymphoma subtypes in Shanxi according to latest WHO classification].
Wang JF; Wang YZ; Chen ZW; Taylor RC
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):218-23. PubMed ID: 16776979
[TBL] [Abstract][Full Text] [Related]
13. [Classical Hodgkin's lymphoma: biology and grey zones].
Gaulard P; Brousse N
Ann Pathol; 2004 Sep; 24(4):330-48. PubMed ID: 15567950
[TBL] [Abstract][Full Text] [Related]
14. Histopathology of Hodgkin's lymphoma.
Eberle FC; Mani H; Jaffe ES
Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308
[TBL] [Abstract][Full Text] [Related]
15. How immunologic and genetic biomarkers impact Hodgkin lymphoma classification, diagnosis, and management: a huge potential that yet needs to be exploited.
Carbone A; Gloghini A
Int J Biol Markers; 2018 May; 33(2):137-140. PubMed ID: 29099538
[TBL] [Abstract][Full Text] [Related]
16. [Hodgkin's disease--an entity?].
Hansmann ML
Verh Dtsch Ges Pathol; 1992; 76():24-36. PubMed ID: 1283267
[TBL] [Abstract][Full Text] [Related]
17. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
Kamel OW; Gelb AB; Shibuya RB; Warnke RA
Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
[TBL] [Abstract][Full Text] [Related]
18. [WHO classification of Hodgkin's lymphoma and its molecular pathological relevance].
Hansmann ML; Willenbrock K
Pathologe; 2002 May; 23(3):207-18. PubMed ID: 12089788
[TBL] [Abstract][Full Text] [Related]
19. T-cell rich b-cell non-hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance hodgkin's disease.
De Jong D; Van Gorp J; Sie-Go D; Van Heerde P
Histopathology; 1996 Jan; 28(1):15-24. PubMed ID: 8838116
[TBL] [Abstract][Full Text] [Related]
20. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
